Company Filing History:
Years Active: 2005-2008
Title: Lene Andresen: Innovator in Pharmaceutical Composition
Introduction
Lene Andresen is a notable inventor based in Rødovre, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the development of crystalline compositions. With a total of 2 patents, her work has the potential to impact the treatment of various medical conditions.
Latest Patents
Lene's latest patents focus on crystalline compositions containing escitalopram. One of her patents discloses crystalline particles of escitalopram oxalate with a particle size of at least 40 µm. The patent also details a method for the manufacture of these crystalline particles and pharmaceutical compositions that comprise them. This innovation is crucial for enhancing the efficacy and delivery of escitalopram in therapeutic applications.
Career Highlights
Lene Andresen is associated with H. Lundbeck A/S, a prominent company in the pharmaceutical industry. Her work at Lundbeck has allowed her to explore and develop innovative solutions in the field of mental health medications. Her contributions are recognized within the company and the broader scientific community.
Collaborations
Lene has collaborated with esteemed colleagues such as Troels Volsgaard Christensen and Ken Liljegren. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Lene Andresen's work exemplifies the spirit of innovation in the pharmaceutical industry. Her patents on escitalopram compositions highlight her commitment to improving medical treatments. Through her career at H. Lundbeck A/S, she continues to make strides in pharmaceutical research and development.